Page last updated: 2024-09-03

imatinib mesylate and Cardiovascular Abnormalities

imatinib mesylate has been researched along with Cardiovascular Abnormalities in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abraham, I; Vincelette, ND; Yun, S1
Dogné, JM; Douxfils, J; Haguet, H1

Other Studies

2 other study(ies) available for imatinib mesylate and Cardiovascular Abnormalities

ArticleYear
Multiple Causes of Cardiotoxic Effects in Patients With Chronic Myeloid Leukemia.
    JAMA oncology, 2016, Jun-01, Volume: 2, Issue:6

    Topics: Cardiotoxicity; Cardiovascular Abnormalities; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Protein Kinase Inhibitors

2016
Multiple Causes of Cardiotoxic Effects in Patients With Chronic Myeloid Leukemia-Reply.
    JAMA oncology, 2016, Jun-01, Volume: 2, Issue:6

    Topics: Cardiotoxicity; Cardiovascular Abnormalities; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive

2016